TherapeuticsMD

Company snapshot

TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. We create products to address the unique changes and challenges women experience through every stage of their lives. With momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to

• 6 active pipeline program(s) linked via ClinicalTrials.gov.
• 6 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for TherapeuticsMD. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for TherapeuticsMD.

1. Jun 8, 2026 Clinical update

   Segesterone Acetate and Ethinyl Estradiol — Phase 1

2. Jun 8, 2026 Clinical update

   Segesterone Acetate and Ethinyl Estradiol — Phase 1

3. Jun 8, 2026 Clinical update

   Progesterone — Phase 3

4. Jun 8, 2026 Clinical update

   oral estradiol 1.0 mg — Phase 3

5. May 23, 2026 Clinical update

   Estradiol — Phase 3

View all clinical trial activity →

• What is TherapeuticsMD?

  TherapeuticsMD is a pharma organization headquartered in Boca Raton, USA. It trades on NYSE under ticker TXMD. Primary therapeutic focus areas include Menopause, Vulvovaginal Atrophy, Secondary Amenorrhea, Contraception, Women. NovaPharmaNews links 6 clinical program(s), 0 drug p

• Is TherapeuticsMD publicly traded?

  Yes. TherapeuticsMD is listed with ticker TXMD on NYSE per SEC EDGAR records linked on this profile.

• What drugs does TherapeuticsMD develop or market?

  We link 6 drug profile(s) where TherapeuticsMD is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/therapeuticsmd#company-drugs.

• What are the latest developments for TherapeuticsMD?

  In the last 12 months our linked public records show 6 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does TherapeuticsMD focus on?

  TherapeuticsMD focuses on Menopause, Vulvovaginal Atrophy, Secondary Amenorrhea based on our analysis of their pipeline programs and drug development activities.